feed,title,long_url,short_url
Benzinga,Biogen Buys Acute Ischemic Stroke Candidate For One-Time Payment Of $18M,https://benzinga.com/general/biotech/21/05/21082369/biogen-buys-acute-ischemic-stroke-candidate-for-one-time-payment-of-18m,https://j.mp/2RhkFnM
Benzinga,Voyager Therapeutics' Vectorized Anti-Tau Antibody Shows Encouraging Preclinical Data In CNS Disorders,https://benzinga.com/general/biotech/21/05/21081743/voyager-therapeutics-vectorized-anti-tau-antibody-shows-encouraging-preclinical-data-in-cns-disor,https://j.mp/3o85TvQ
